← Back to Clinical Trials
Recruiting NCT07435805

NCT07435805 Long-Term Health Effects of Previous Coronavirus Disease 2019 (COVID-19) in Patients Undergoing Preoperative Anesthesia Evaluation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07435805
Status Recruiting
Phase
Sponsor Elazıg Fethi Sekin Sehir Hastanesi
Condition Post-COVID Condition
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2025-12-01
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Post-COVID Clinical Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2025-12-01 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Coronavirus Disease 2019 (COVID-19) pandemic has resulted in persistent health problems in a significant proportion of individuals after recovery from the acute infection. These long-term manifestations, commonly referred to as post-COVID-19 condition or long COVID, may involve respiratory, cardiovascular, neurological, psychological, and general health domains. Understanding these sequelae is particularly important in patients undergoing preoperative anesthesia evaluation, as residual symptoms may influence perioperative risk assessment and clinical decision-making. This cross-sectional observational study aims to evaluate the long-term clinical and health effects of previous COVID-19 infection in adult patients presenting to the preoperative anesthesia clinic. Patients aged 18 years and older who report a history of confirmed COVID-19 infection will be included. Clinical data related to the acute infection period (disease severity, hospitalization, intensive care unit (ICU) admission, oxygen therapy, and radiological findings) will be retrospectively obtained from hospital records. At the time of preoperative assessment, participants will complete a structured post-COVID-19 clinical questionnaire to evaluate persistent symptoms across multiple organ systems. The study seeks to determine the prevalence and characteristics of long-term post-COVID-19 symptoms and to explore potential associations between acute disease severity and ongoing health complaints. No additional medical intervention will be performed as part of this research.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years Presentation to the preoperative anesthesia clinic Self-reported history of laboratory-confirmed COVID-19 infection Ability to provide informed consent Willingness to complete the post-COVID clinical questionnaire Exclusion Criteria: * Age \<18 years No history of COVID-19 infection Refusal to participate or incomplete questionnaire Cognitive impairment or communication difficulties preventing reliable data collection

Contact & Investigator

Central Contact

OĞUZ KAĞAN BULUT, MD

✉ oguzkaganbulut@hotmail.com

📞 +905327858130

Frequently Asked Questions

Who can join the NCT07435805 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Post-COVID Condition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07435805 currently recruiting?

Yes, NCT07435805 is actively recruiting participants. Contact the research team at oguzkaganbulut@hotmail.com for enrollment information.

Where is the NCT07435805 trial being conducted?

This trial is being conducted at Elâzığ, Turkey (Türkiye).

Who is sponsoring the NCT07435805 clinical trial?

NCT07435805 is sponsored by Elazıg Fethi Sekin Sehir Hastanesi. The trial plans to enroll 400 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology